Copyright 2013 Medical News TodayLatest Health News and Medical News posted throughout the day, every day.http://www.medicalnewstoday.com/sections/pancreatic-cancer/admin@medicalnewstoday.com (MNT Admin)editors@medicalnewstoday.com (MNT Editors)en-us Wed, 22 May 2013 11:00:00 PDThttp://www.medicalnewstoday.com/articles/260896.phphttp://www.medicalnewstoday.com/articles/260896.php Using bacteria to ferry radioisotopes commonly used in cancer therapy directly into pancreatic cancer cells in mice, researchers in the US were able dramatically to reduce the number of secondary tumors that arise when the cancer spreads to other parts of the body (metastases)...Pancreatic Cancer Tue, 21 May 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/260734.phphttp://www.medicalnewstoday.com/releases/260734.phpResearchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis - two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic "juices" can identify almost all cases of pancreatic cancer, their study shows. The findings were being presented at Digestive Disease Week 2013 in Orlando, Fla...Pancreatic Cancer Sat, 18 May 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/260628.phphttp://www.medicalnewstoday.com/releases/260628.phpIn the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate cancers...Pancreatic Cancer Wed, 15 May 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/260509.phphttp://www.medicalnewstoday.com/releases/260509.php In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options. Pancreatic cancer kills nearly 38,000 Americans annually, making it a leading cause of cancer death...Pancreatic Cancer Wed, 24 Apr 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/259502.phphttp://www.medicalnewstoday.com/releases/259502.phpResearchers at Albert Einstein College of Medicine of Yeshiva University have developed a therapy for pancreatic cancer that uses Listeria bacteria to selectively infect tumor cells and deliver radioisotopes into them...Pancreatic Cancer Wed, 24 Apr 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/259505.phphttp://www.medicalnewstoday.com/releases/259505.phpPancreatic cancer is the fourth leading cause of death from cancer, and while family physicians in Canada only see 1 case a year, the number of cases is expected to increase as the population ages. A review in CMAJ (Canadian Medical Association Journal) provides an evidence-based overview of diagnosis and treatment of the disease for general physicians...Pancreatic Cancer Tue, 23 Apr 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/259448.phphttp://www.medicalnewstoday.com/releases/259448.phpScientists at the Walter and Eliza Hall Institute and their collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients. The development of the compound, called WEHI-539, is an important step towards the design of a potential new anti-cancer agent...Lymphoma / Leukemia / Myeloma Thu, 11 Apr 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/258869.phphttp://www.medicalnewstoday.com/releases/258869.phpResults of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This is the first trial in which orally administered Rigosertib, a dual kinase inhibitor, was studied in solid tumors...Cancer / Oncology Wed, 10 Apr 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/258788.phphttp://www.medicalnewstoday.com/releases/258788.phpA novel combination of two drugs has shown anti-cancer activity in patients who had incurable solid tumors and carried a germline mutation in their BRCA genes, Dana-Farber Cancer Institute researchers reported at the American Association for Cancer Research annual meeting in Washington, April 6-10...Pancreatic Cancer Fri, 05 Apr 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/258626.phphttp://www.medicalnewstoday.com/releases/258626.phpResearchers at Moffitt Cancer Center have determined that the overexpression of microRNA-155 (miR-155), a short, single strand of ribonucleic acid encoded by the miR-155 host gene, promotes the growth of blood vessels in tumors, tumor inflammation, and metastasis. As a therapeutic target, miR-155 could potentially provide a new avenue of treatment when targeted with drugs to suppress its activity...Back Pain Tue, 02 Apr 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/258446.phphttp://www.medicalnewstoday.com/releases/258446.phpA new diagnostic test that uses a scientific technique known as metabolomic analysis may be a safe and easy screening method that could improve the prognosis of patients with pancreatic cancer through earlier detection...Pancreatic Cancer Mon, 01 Apr 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/258365.phphttp://www.medicalnewstoday.com/releases/258365.phpDana-Farber Cancer Institute scientists and colleagues have discovered that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control the deadly cancer. Cancer cells are known to "rewire" their metabolic circuits differently from normal cells to provide energy for cancerous growth...Pancreatic Cancer Mon, 01 Apr 2013 00:00:00 PDThttp://www.medicalnewstoday.com/articles/258448.phphttp://www.medicalnewstoday.com/articles/258448.phpType 2 diabetes patients who are on incretin therapy have a higher risk of developing abnormalities in their pancreas compared to their counterparts on other types of diabetes therapies, researchers from the Larry L. Hillblom Islet Research Center at UCLA and the Diabetes Center at the University of Florida reported in the journal Diabetes...Diabetes Sat, 30 Mar 2013 01:00:00 PDThttp://www.medicalnewstoday.com/articles/258417.phphttp://www.medicalnewstoday.com/articles/258417.phpA new diagnostic test that uses a scientific method called metabolomic analysis could help detect pancreatic cancer early, and therefore, improve the prognosis of patients with the disease. This new screening method is safe and easy, according to new research published in Cancer Epidemiology, Biomarkers, & Prevention, a journal of the American Association for Cancer Research...Pancreatic Cancer Fri, 29 Mar 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/258297.phphttp://www.medicalnewstoday.com/releases/258297.phpIndividuals who had taken a type of drug commonly used to treat Type 2 diabetes showed abnormalities in the pancreas, including cell proliferation, that may be associated with an increased risk of neuroendocrine tumors, according to a new study by researchers from UCLA and the University of Florida. Their findings were published online in the journal Diabetes. The researchers, from the Larry L...Diabetes Wed, 27 Mar 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/258199.phphttp://www.medicalnewstoday.com/releases/258199.phpResearchers at the University of North Carolina at Chapel Hill have discovered that a protein found in the cells surrounding pancreatic cancers play a role in the spread of the disease to other parts of the body...Pancreatic Cancer Fri, 15 Mar 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/257606.phphttp://www.medicalnewstoday.com/releases/257606.phpA University of Colorado Cancer study published this week in the journal Carcinogenesis shows that bitter melon juice restricts the ability of pancreatic cancer cells to metabolize glucose, thus cutting the cells' energy source and eventually killing them. "Three years ago researchers showed the effect of bitter melon extract on breast cancer cells only in a Petri dish...Pancreatic Cancer Sat, 23 Feb 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/256704.phphttp://www.medicalnewstoday.com/releases/256704.php The research was published recently in the journal Technology in Cancer Research and Treatment. The article describes experiments using ultrasonic molecular imaging (USMI) and Dynamic Contrast Enhanced-Perfusion Imaging (DCE-PI) to measure response to therapy for pancreatic cancer...Pancreatic Cancer Tue, 19 Feb 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/256462.phphttp://www.medicalnewstoday.com/releases/256462.phpIn laboratory studies, scientists at the Johns Hopkins Kimmel Cancer Center have developed a way to personalize chemotherapy drug selection for cancer patients by using cell lines created from their own tumors...Pancreatic Cancer Fri, 15 Feb 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/256331.phphttp://www.medicalnewstoday.com/releases/256331.phpA recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammation A team from the Perelman School of Medicine at the University of Pennsylvania profiled gene expression of mouse pancreatic ductal and duct-like cells from different states - embryonic development, acute pancreatitis and K-ras mutation-driv...Pancreatic Cancer Fri, 08 Feb 2013 00:00:00 PDThttp://www.medicalnewstoday.com/releases/255954.phphttp://www.medicalnewstoday.com/releases/255954.php When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist...Breast Cancer Wed, 06 Feb 2013 02:00:00 PDThttp://www.medicalnewstoday.com/releases/255907.phphttp://www.medicalnewstoday.com/releases/255907.phpStudy finds patients with low RRM1 expression have better survival with gemcitabine Moffitt Cancer Center researchers have identified a gene that may better predict survival for pancreatic adenocarcinoma, the fourth leading cause of cancer deaths in the United States. Researcher Richard Kim, M.D...Pancreatic Cancer Mon, 04 Feb 2013 01:00:00 PDThttp://www.medicalnewstoday.com/releases/255739.phphttp://www.medicalnewstoday.com/releases/255739.phpApproval from the Norwegian Medicines Agency (NOMA) to start clinical phase I/II study in Norway was received in November, and first patient was recruited in January. 18-24 patients will be included in the clinical Phase I/II study. Results from the Phase I part are expected in first half of 2013...Pancreatic Cancer Tue, 29 Jan 2013 02:00:00 PDThttp://www.medicalnewstoday.com/releases/255502.phphttp://www.medicalnewstoday.com/releases/255502.phpPivotal Phase III study with investigational hypoxia-targeted drug aims to enroll 660 patients Merck Serono, a division of Merck, Darmstadt, Germany, have announced the initiation of the global Phase III MAESTRO study, assessing the efficacy and safety of investigational hypoxia-targeted drug TH-302 in combination with gemcitabine in patients with previously untreated, locally...Pancreatic Cancer Thu, 24 Jan 2013 13:00:00 PDThttp://www.medicalnewstoday.com/articles/255388.phphttp://www.medicalnewstoday.com/articles/255388.phpCelegene Corp's drug Abraxane (paclitaxel protein-bound particles for injectable suspension) was found to be effective at improving overall survival among pancreatic cancer patients when combined with chemotherapy, according to results from the drug's phase III clinical trial. Even though Pancreatic cancer is a relatively uncommon form of cancer - making up only 2...Pancreatic Cancer